Prostate Testing for Cancer and Treatment (ProtecT)

Prostate cancer is a serious health problem. There are 35,000 new cases every year in the UK, and around 10,000 deaths. The ProtecT study is a research project taking place in nine parts of the UK.

ProtecT study centres

  • Bristol Southmead Hospital
    Lead Urologist: Mr Ed Rowe
  • Newcastle Freeman Hospital
    Lead Urologist: Mr Philip Powell
  • Sheffield Royal Hallamshire Hospital
    Lead Urologist: Mr Derek Rosario
  • Birmingham Queen Elizabeth Hospital
    Lead Urologist: Mr Alan Doherty
  • Cardiff University Hospital of Wales
    Lead Urologist: Professor Howard Kynaston
  • Edinburgh Western General Hospital
    Lead Urologist: Mr Prasad Bollina
  • Cambridge Addenbrookes Hospital
    Lead Urologist: Professor David Neal
  • Leicester Leicester General Hospital
    Lead Urologist: Mr Roger Kockelbergh
  • Leeds St James Hospital
    Lead Urologist: Mr Alan Paul

About the study

The aim of the ProtecT study is to find out the best ways of treating prostate cancer.

Read more about the study

Taking part

Further funding has now been granted for the follow-up phase of the study.

Read more about taking part

Potential collaborators

We welcome collaboration from potential investigators carrying out studies in the field of urological research.

Read more about collaborating


The ProtecT Study
School of Social and Community Medicine
University of Bristol
Canynge Hall
39 Whatley Road
Bristol, BS8 2PS
United Kingdom
Tel: Freephone 0800 783 3167


International Standard Randomised Controlled Trial Number: ISRCTN20141297